Table 3. Association of FC-MLR with clinical characteristics in patients with EOC.

Variables	FC-MLR grouped			P
	Group 1	Group 2	Group 3
n	44	48	63
CA125 (U/mL)	13.9 (10.6, 31.2)	30.2 (16.9, 213.2)	76.2 (31.2, 548.3)	<0.001
Stage of EOC
< IIIb	34	27	10
≥ IIIb	10	21	53	<0.001
Lymphatic metastasis
No	39	35	45
Yes	5	13	18	<0.001
Venous metastasis
No	42	38	40
Yes	2	10	23	<0.001
5-year survival
No	1	29	28
Yes	43	19	35	<0.001

FC-MLR, combined fibrinogen concentrations and the monocyte-to-lymphocyte ratio; EOC, epithelial ovarian cancer; CA, carbohydrate antigen.